Oklahoma Cancer Screening Access Hub
Oklahoma TRUST Access Hub
This program brings cancer screening trials and enrollment support to people aged 45–75 across rural, tribal, and urban communities in Oklahoma.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Oklahoma Hlth Sciences Ctr NIH-funded |
| Lab location | 1 site (Oklahoma City, United States) |
| Project ID | NIH-11241163 on NIH RePORTER |
What this research studies
If you live in Oklahoma, this hub works with local clinics so you can join cancer screening trials near your home instead of traveling far. It connects more than 85,000 people aged 45–75 who get care at partner sites with the Vanguard screening study and future screening research. The team helps clinics with leadership, paperwork, and regulatory steps so trials can run smoothly in tribal, rural, and urban settings. That means easier enrollment, more chances for early screening, and trial visits offered in community healthcare facilities.
Who could benefit from this research
Good fit: Adults aged 45–75 who receive care at participating OK TRUST affiliate clinics, including patients in rural and tribal communities, are the primary candidates.
Not a fit: People younger than 45, those who do not receive care at participating clinics, or patients seeking treatment for an existing cancer rather than screening are less likely to benefit.
Why it matters
Potential benefit: If successful, it could make it much easier for Oklahoma residents to access cancer screening trials locally, potentially improving early detection and care options.
How similar studies have performed: Similar community-based hub and outreach programs have increased trial enrollment in other regions, though statewide implementation in largely rural and tribal areas is less common.
Where this research is happening
Oklahoma City, United States
- University of Oklahoma Hlth Sciences Ctr — Oklahoma City, United States (Active)
Researchers
- Principal investigator: Doescher, Mark P — University of Oklahoma Hlth Sciences Ctr
- Study coordinator: Doescher, Mark P
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.